Read + Share
Song L, Xu Q, Lizaso A, Zhang Y, et al. Brigatinib After Progression From Alectinib or Crizotinib: Paving the Way for
Treatment Sequencing of ALK Inhibitors in ALK-Positive NSCLC. J Thorac Oncol 2021;16:349-351.
PMID: 33641716
|
 |
|
Song L, Xu Q, Lizaso A, Zhang Y, et al. Brigatinib After Progression From Alectinib or Crizotinib: Paving the Way for
Treatment Sequencing of ALK Inhibitors in ALK-Positive NSCLC. J Thorac Oncol 2021;16:349-351.
PMID: 33641716
|
|
|
|